Oncology & Cancer

Promising approach to mitigate complications of leukemia treatment

Researchers at Baylor College of Medicine and collaborating institutions have engineered immune cells to control two major life-threatening complications, namely graft-vs-host disease (GvHD) and cancer relapse, which typically ...

Diseases, Conditions, Syndromes

Isolating the molecules that trigger emphysema

Emphysema is the major debilitating component of the lethal chronic obstructive pulmonary disease (COPD), which was the third leading cause of death worldwide in 2019, causing 3.23 million deaths.

Medical research

Researchers turn cancer cells into less harmful cell types

Cancer occurs when cells grow uncontrollably and spread to other organs in the body. Cancer cells differ from normal cells in many ways. One characteristic of cancer cells is their high adaptability to different environments ...

Oncology & Cancer

Killer T cells get better with age, study finds

The human immune system is a thing of wonder. Up until now it had been widely assumed that the ability of killer T cells to destroy tumor cells and pathogens would deteriorate with age. It turns out, however, that the opposite ...

Medical research

In small study, CAR-T therapy pushes lupus into remission

While there's no cure for lupus and treatments don't work for many of the 1.5 million people who live with the disease in the United States, a new study shows a cancer therapy may kick hard-to-treat lupus into remission.

page 37 from 40